QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint Inhibitors
ImmunityBio, Inc.
ImmunityBio, Inc.
Merck Sharp & Dohme LLC
Marengo Therapeutics, Inc.
UNICANCER
Fate Therapeutics
Incyte Corporation
Incyte Corporation
Gustave Roussy, Cancer Campus, Grand Paris